chr1-77962829-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000370768.7(FUBP1):āc.1285A>Gā(p.Ile429Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,612,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I429F) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000370768.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FUBP1 | NM_003902.5 | c.1285A>G | p.Ile429Val | missense_variant | 14/20 | ENST00000370768.7 | NP_003893.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FUBP1 | ENST00000370768.7 | c.1285A>G | p.Ile429Val | missense_variant | 14/20 | 1 | NM_003902.5 | ENSP00000359804 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251256Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135778
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1460028Hom.: 0 Cov.: 28 AF XY: 0.0000110 AC XY: 8AN XY: 726466
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.1285A>G (p.I429V) alteration is located in exon 14 (coding exon 14) of the FUBP1 gene. This alteration results from a A to G substitution at nucleotide position 1285, causing the isoleucine (I) at amino acid position 429 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at